Hernia mesh showdown: fortiva vs strattice – which works better?
NCT ID NCT05572021
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two biologic meshes, Fortiva and Strattice, used to repair ventral hernias. Researchers planned to track hernia recurrence and mesh-related complications in patients. However, the study was terminated early and only enrolled 6 people, so no reliable conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fortiva biologic mesh and Strattice biologic mesh
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRAL HERNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Carolinas Medical Center
Charlotte, North Carolina, 28204, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict mesh infections before they happen? a new study aims to find out
- Which hernia repair technique causes less pain? a trial puts two methods Head-to-Head
- Can a robot help heal large hernias faster? a trial puts it to the test
- Can a flap made from the hernia sac itself prevent mesh complications?
- Could a muscle relaxant cut opioid use after hernia surgery?
- Physical therapy after hernia surgery shows promise in small trial